XML 59 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income/(Loss)
Balance (in shares) at Mar. 31, 2018   52,343      
Balance at Mar. 31, 2018 $ 752,429 $ 523 $ 503,955 $ 266,942 $ (18,991)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Employee stock purchase plan (in shares)   45      
Employee stock purchase plan 1,780 $ 1 1,779    
Exercise of stock options (in shares)   75      
Exercise of stock options 2,831 $ 1 2,830    
Shares repurchased (in shares)   (888)      
Shares repurchased (80,000) $ (9) (4,552) (75,439)  
Issuance of restricted stock, net of cancellations (in shares)   67      
Issuance of restricted stock, net of cancellations 0        
Share-based compensation expense 3,379   3,379    
Cumulative effect of change in accounting principles 1,177     1,177  
Net income (2,819)     (2,819)  
Other comprehensive income (loss) (4,719)       (4,719)
Balance (in shares) at Jun. 30, 2018   51,642      
Balance at Jun. 30, 2018 674,058 $ 516 507,391 189,861 (23,710)
Balance (in shares) at Mar. 31, 2018   52,343      
Balance at Mar. 31, 2018 752,429 $ 523 503,955 266,942 (18,991)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 34,184        
Balance (in shares) at Dec. 29, 2018   50,993      
Balance at Dec. 29, 2018 643,129 $ 510 531,131 140,584 (29,096)
Balance (in shares) at Jun. 30, 2018   51,642      
Balance at Jun. 30, 2018 674,058 $ 516 507,391 189,861 (23,710)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   125      
Exercise of stock options 4,295 $ 1 4,294    
Shares repurchased (in shares)   (182)      
Shares repurchased 0 $ (2) 14,213 (14,211)  
Issuance of restricted stock, net of cancellations (in shares)   40      
Issuance of restricted stock, net of cancellations 1 $ 1      
Share-based compensation expense 4,582   4,582    
Net income 18,726     18,726  
Other comprehensive income (loss) (323)       (323)
Balance (in shares) at Sep. 29, 2018   51,625      
Balance at Sep. 29, 2018 701,339 $ 516 530,480 194,376 (24,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Employee stock purchase plan (in shares)   22      
Employee stock purchase plan 1,474   1,474    
Exercise of stock options (in shares)   66      
Exercise of stock options 2,321 $ 1 2,320    
Shares repurchased (in shares)   (771)      
Shares repurchased (80,000) $ (7) (7,924) (72,069)  
Issuance of restricted stock, net of cancellations (in shares)   51      
Issuance of restricted stock, net of cancellations (1)   (1)    
Share-based compensation expense 4,782   4,782    
Net income 18,277     18,277  
Other comprehensive income (loss) (5,063)       (5,063)
Balance (in shares) at Dec. 29, 2018   50,993      
Balance at Dec. 29, 2018 643,129 $ 510 531,131 140,584 (29,096)
Balance (in shares) at Mar. 30, 2019   51,020      
Balance at Mar. 30, 2019 667,868 $ 510 536,320 161,418 (30,380)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Employee stock purchase plan (in shares)   25      
Employee stock purchase plan 1,830   1,830    
Exercise of stock options (in shares)   85      
Exercise of stock options 3,635 $ 1 3,634    
Shares repurchased (in shares)   (616)      
Shares repurchased (75,000) $ (6) (21,473) (53,521)  
Issuance of restricted stock, net of cancellations (in shares)   257      
Issuance of restricted stock, net of cancellations 0 $ 3 (3)    
Share-based compensation expense 4,730   4,730    
Net income (8,479)     (8,479)  
Other comprehensive income (loss) (3,618)       (3,618)
Balance (in shares) at Jun. 29, 2019   50,771      
Balance at Jun. 29, 2019 590,966 $ 508 525,038 99,418 (33,998)
Balance (in shares) at Mar. 30, 2019   51,020      
Balance at Mar. 30, 2019 667,868 $ 510 536,320 161,418 (30,380)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 58,902        
Other comprehensive income (loss) (3,325)        
Balance (in shares) at Dec. 28, 2019   50,391      
Balance at Dec. 28, 2019 574,580 $ 504 537,913 69,868 (33,705)
Balance (in shares) at Jun. 29, 2019   50,771      
Balance at Jun. 29, 2019 590,966 $ 508 525,038 99,418 (33,998)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   64      
Exercise of stock options 2,410 $ 1 2,409    
Shares repurchased (in shares)   (360)      
Shares repurchased (50,000) $ (4) 1,274 (51,270)  
Issuance of restricted stock, net of cancellations (in shares)   133      
Issuance of restricted stock, net of cancellations 0 $ 1 (1)    
Share-based compensation expense 5,000   5,000    
Net income 37,486     37,486  
Other comprehensive income (loss) (2,108)       (2,108)
Balance (in shares) at Sep. 28, 2019   50,608      
Balance at Sep. 28, 2019 583,754 $ 506 533,720 85,634 (36,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Employee stock purchase plan (in shares)   20      
Employee stock purchase plan 1,538   1,537    
Exercise of stock options (in shares)   60      
Exercise of stock options 1,667 $ 1 1,667    
Shares repurchased (in shares)   (411)      
Shares repurchased (50,000) $ (4) (4,335) (45,661)  
Issuance of restricted stock, net of cancellations (in shares)   114      
Issuance of restricted stock, net of cancellations 0 $ 1 (1)    
Share-based compensation expense 5,325   5,325    
Net income 29,895     29,895  
Other comprehensive income (loss) 2,401       2,401
Balance (in shares) at Dec. 28, 2019   50,391      
Balance at Dec. 28, 2019 $ 574,580 $ 504 $ 537,913 $ 69,868 $ (33,705)